{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:53:24Z","timestamp":1793066004594,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020327","name":"Compagnie Nationale du Rh\u00f4ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajt.2025.10.018","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:39:06Z","timestamp":1761788346000},"page":"633-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infection"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8196-4395","authenticated-orcid":false,"given":"N.","family":"Kasriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9787-1421","authenticated-orcid":false,"given":"S.","family":"Alain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-2479","authenticated-orcid":false,"given":"I.","family":"Benotmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1930-8964","authenticated-orcid":false,"given":"N.","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Danthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4595-7570","authenticated-orcid":false,"given":"C.","family":"Tinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Robier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0876-7508","authenticated-orcid":false,"given":"L.","family":"Di Ascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5793-6174","authenticated-orcid":false,"given":"D.","family":"Anglicheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-2171","authenticated-orcid":false,"given":"C.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Planchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-5617","authenticated-orcid":false,"given":"C.","family":"Garrouste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1664-2879","authenticated-orcid":false,"given":"P.","family":"Gatault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-6272","authenticated-orcid":false,"given":"G.","family":"Melica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-427X","authenticated-orcid":false,"given":"M.","family":"Matignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-4495","authenticated-orcid":false,"given":"A.","family":"Corbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-1256","authenticated-orcid":false,"given":"C.","family":"Gosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6651-6390","authenticated-orcid":false,"given":"C.","family":"Mariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-8869","authenticated-orcid":false,"given":"Y.","family":"Tamzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-7655","authenticated-orcid":false,"given":"F.","family":"Vuotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-1196","authenticated-orcid":false,"given":"M.","family":"Maanaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-1592","authenticated-orcid":false,"given":"M.","family":"Giral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-1444","authenticated-orcid":false,"given":"T.","family":"Legris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9928-4351","authenticated-orcid":false,"given":"C.","family":"Presne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-9719","authenticated-orcid":false,"given":"A.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-4859","authenticated-orcid":false,"given":"D.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-7506","authenticated-orcid":false,"given":"T.","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7991-1733","authenticated-orcid":false,"given":"A.","family":"Truffot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-0848","authenticated-orcid":false,"given":"I.","family":"Garrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8987-2929","authenticated-orcid":false,"given":"P.","family":"Merville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9213-6196","authenticated-orcid":false,"given":"L.","family":"Couzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-3825","authenticated-orcid":false,"given":"H.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajt.2025.10.018_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ndt\/gfad193","article-title":"Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017","volume":"39","author":"Pfirmann","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.10.018_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.018_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2023.9106","article-title":"Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in high-risk kidney transplant recipients: a randomized clinical trial","volume":"330","author":"Limaye","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.018_bib4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial","volume":"75","author":"Avery","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.018_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad018","article-title":"Cytomegalovirus DNAemia requiring (val)ganciclovir treatment for more than 8 weeks is a key factor in the development of antiviral drug resistance","volume":"10","author":"Acquier","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.ajt.2025.10.018_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"\u00c5sberg","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.018_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/jiad293","article-title":"Drug resistance assessed in a phase 3 clinical trial of maribavir therapy for refractory or resistant cytomegalovirus infection in transplant recipients","volume":"229","author":"Chou","year":"2024","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ajt.2025.10.018_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15480","article-title":"Evaluating real-world experience with maribavir for treatment of refractory\/resistant cytomegalovirus in renal transplant recipients","volume":"38","author":"Beechar","year":"2024","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.10.018_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae335","article-title":"Real-world experience with maribavir for treatment of cytomegalovirus infection in high-risk solid organ transplant recipients","volume":"11","author":"Ni","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.018_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14929","article-title":"Real world experience with maribavir for the treatment of cytomegalovirus in solid organ transplant recipients","volume":"37","author":"Sabatino","year":"2023","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.018_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac686","article-title":"Maribavir for cytomegalovirus treatment in the real world-not a silver bullet","volume":"10","author":"Fung","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.018_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1399-3062.2010.00550.x","article-title":"Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients","volume":"12","author":"Avery","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.018_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the Transplant Associated Virus Infections Forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ajt.2025.10.018_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/cid\/ciy696","article-title":"Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials","volume":"68","author":"Chemaly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajt.2025.10.018_bib15","article-title":"NDA 215596: maribavir tablets. Treatment of resistant or refractory cytomegalovirus infection and disease in transplant patients","year":"2021","journal-title":"Antimicrobial Drugs Advisory Committee Meeting"},{"issue":"10","key":"10.1016\/j.ajt.2025.10.018_bib16","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/ajt.16718","article-title":"Letermovir in lung transplant recipients with cytomegalovirus infection: a retrospective observational study","volume":"21","author":"Veit","year":"2021","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.018_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/cid\/ciy549","article-title":"Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical trial","volume":"68","author":"Smith","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ajt.2025.10.018_bib18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ajt.2024.04.009","article-title":"Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant","volume":"24","author":"Khoury","year":"2024","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525030692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525030692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:36:22Z","timestamp":1778621782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525030692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1600613525030692"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.10.018","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}